https://healthtimesrhodeisland.com/article/835412773-valitor-highlights-three-fold-increase-with-vltr-559-in-sustained-potency-and-durability-over-aflibercept-in-preclinical-ocular-wet-amd-models
Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over...